HARP - Harpoon Therapeutics Inc
Close
23.01
0.020 0.087%
Share volume: 0
Last Updated: Fri 08 Mar 2024 10:00:00 PM CET
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$22.99
0.02
0.09%
Summary score
27%
Profitability
25%
Dept financing
25%
Liquidity
47%
Performance
25%
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-146.41%
Return on assets
-11.05%
Return on sales
-251.3%
Return on invested capital
16.77%
Total debt ratio
70.56%
Debt ratio change over timeo
-0.58%
Current Ratio
2.8%
Quick Ratio
2.17%
Cash Position Ratio
2.1%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-482.8%
Return on assets
-14.38%
Return on sales
-208.77%
Return on invested capital
31.16%
Total debt ratio
94.38%
Debt ratio change over timeo
-2.09%
Current Ratio
1.58%
Quick Ratio
1.58%
Cash Position Ratio
1.49%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
-39.68%
Return on assets
-25.51%
Return on sales
-272.91%
Return on invested capital
37.35%
Total debt ratio
90.46%
Debt ratio change over time
0.33%
Current Ratio
1.89%
Quick Ratio
1.89%
Cash Position Ratio
1.75%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
849.36%
Return on assets
-108.59%
Return on sales
-476.16%
Return on invested capital
-49.73%
Total debt ratio
-58.37%
Debt ratio change over time
-0.58%
Current Ratio
0.83%
Quick Ratio
1.72%
Cash Position Ratio
1.02%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | HARP | SGEN | NK | SRNG |
---|---|---|---|---|
Return on equity | -146.41% | -2.6% | -14.24% | 0% |
Return on assets | -11.05% | -2.4% | -12.07% | 0% |
Return on sales | -251.3% | -25.64% | 0% | 0% |
Return on invested capital | 16.77% | -55.3% | -26.3% | 0% |
Profitability | 25% | 0% | 25% | 50% |
Total debt ratio | 70.56% | 19.36% | 16.14% | 0% |
Debt ratio change over time | -0.58% | -1.42% | -1.73% | 0% |
Dept financing | 25% | 7% | 6% | 25% |
Current Ratio | 1.58% | 3.26% | 0% | 0% |
Quick Ratio | 1.58% | 2.66% | 0% | 0% |
Cash Position Ratio | 1.49% | 1.8% | 0% | 0% |
Liquididy | 45% | 74% | 50% | 0% |
Short-term ratios | HARP | SGEN | NK | SRNG |
---|---|---|---|---|
Return on equity | -482.8% | -7.06% | 0% | 0% |
Return on assets | -14.38% | -5.52% | 0% | 0% |
Return on sales | -208.77% | -34.22% | 0% | 0% |
Return on invested capital | 31.16% | -154.82% | 0% | 0% |
Profitability | 25% | 0% | 75% | 0% |
Total debt ratio | 94.38% | 25.43% | 0% | 0% |
Debt ratio change over time | -2.09% | -1.21% | 0% | 0% |
Dept financing | 25% | 7% | 25% | 0% |
Current Ratio | 1.58% | 3.26% | 0% | 0% |
Quick Ratio | 1.58% | 2.66% | 0% | 0% |
Cash Position Ratio | 1.49% | 1.8% | 0% | 0% |
Liquididy | 48% | 75% | 0% | 0% |